Table 5 Characteristics of female participants with vs. without high baPWV in the overall sample

n

1213

363

Age , years

52.8 ±15.2

58.1 ± 13.2

<0.001

baPWV, cm/s

1441 ± 318

2038 ± 566

<0.001

BMI, kg/m ²

23.9 ± 3.3

24.4 ± 3.7

0.026

SBP, mmHg

126.9 ± 19.5

144.2 ± 20.0

<0.001

DBP, mmHg

74.8 ± 10.5

82.5 ± 10.4

0.615

HR, beats/min

71 ± 9

75 ±11

<0.001

TC, mmol/L

4.99 ± 1.0

5.38 ±1.1

<0.001

HDL-C, mmol/L

1.41 ± 0.3

1.35 ±0.3

0.003

LDL-C, mmol/L

2.95 ± 0.9

3.19 ±0.9

<0.001

TG, mmol/L

1.51 ± 0.9

1.80 ± 1.1

<0.001

Fasting glucose, mmol/L

5.31 ± 1.5

5.89 ± 1.9

<0.001

Hypertension, %

40.1

73.3

<0.001

Diabetes, %

17.9

31.9

<0.001

Smoking, %

3.6

4.1

0.638

Stroke, %

3.6

6.3

0.058

Ischemic heart disease, %

6.8

7.9

0.485

Medication

ACEIs/ARBs usage, %

7.0

15.2

<0.001

Statins usage, %

4.6

6.1

0.271

CCBs usage, %

11.2

25.3

<0.001